glp-1 obesity drug news today october 23 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth Alarming rise in weight loss
Description
If pancreatitis is suspected, the patient should discontinue exenatide immediately and seek medical attention
All authors have reviewed the submitted version and agreed to publish the manuscript
Injectable semaglutide was started at 0.25 mg once weekly Even though JMs A1C is fairly well controlled (7.1%), he has established ASCVD
doi: 10.1016/j.cgh.2024.04.038
2016;6:e208
